Axa S.A. Blueprint Medicines Corp Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$54.1 - $110.08 $4.84 Million - $9.85 Million	-89,521 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $1.95 Million - $2.4 Million	-20,700 Reduced 18.78%	89,521 $9.59 Million
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $998,321 - $1.35 Million	12,328 Added 12.59%	110,221 $11.3 Million
Q2 2021 Aug 13, 2021	SELL	$82.78 - $101.0 $615,717 - $751,238	-7,438 Reduced 7.06%	97,893 $8.61 Million
Q1 2021 May 14, 2021	BUY	$90.71 - $108.28 $177,610 - $212,012	1,958 Added 1.89%	105,331 $10.2 Million
Q4 2020 Feb 12, 2021	BUY	$92.08 - $124.48 $267,032 - $360,992	2,900 Added 2.89%	103,373 $11.6 Million
Q3 2020 Nov 13, 2020	SELL	$66.45 - $92.7 $65,918 - $91,958	-992 Reduced 0.98%	100,473 $9.31 Million
Q2 2020 Aug 14, 2020	BUY	$57.09 - $79.27 $2.62 Million - $3.63 Million	45,847 Added 82.43%	101,465 $7.91 Million
Q1 2020 May 15, 2020	BUY	$48.11 - $82.22 $2.68 Million - $4.57 Million	55,618 New	55,618 $3.25 Million
Q4 2019 Feb 18, 2020	SELL	$66.73 - $82.59 $7.18 Million - $8.88 Million	-107,575 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$72.9 - $101.41 $11,736 - $16,327	-161 Reduced 0.15%	107,575 $7.9 Million
Q2 2019 Aug 13, 2019	SELL	$73.54 - $97.8 $1.33 Million - $1.77 Million	-18,054 Reduced 14.35%	107,736 $10.2 Million
Q1 2019 May 14, 2019	BUY	$48.7 - $86.6 $4.65 Million - $8.26 Million	95,386 Added 313.73%	125,790 $10.1 Million
Q3 2018 Nov 08, 2018	SELL	$58.91 - $78.32 $500,735 - $665,720	-8,500 Reduced 21.85%	30,404 $2.37 Million
Q2 2018 Aug 13, 2018	BUY	$60.96 - $101.18 $1.68 Million - $2.79 Million	27,604 Added 244.28%	38,904 $2.47 Million
Q1 2018 May 14, 2018	SELL	$73.28 - $102.95 $109,920 - $154,425	-1,500 Reduced 11.72%	11,300 $1.04 Million
Q4 2017 Feb 13, 2018	BUY	$62.91 - $88.32 $207,603 - $291,456	3,300 Added 34.74%	12,800 $965,000
Q3 2017 Nov 13, 2017	BUY	$42.37 - $69.67 $402,515 - $661,865	9,500	9,500 $662,000

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$612 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.65M
Shares

$609 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

5.39M
Shares

$494 Million
0.06% of portfolio
Wellington Management Group LLP Boston, MA

3.96M
Shares

$363 Million
0.07% of portfolio
State Street Corp Boston, MA

2.77M
Shares

$253 Million
0.01% of portfolio

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.47B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account